Coverage
-
April 08, 2016
The Federal Circuit on Friday upheld a district court's finding that a Purdue Pharma patent for an abuse-resistant variety of OxyContin is invalid as obvious, sealing a win for generic-drug maker Amneal Pharmaceuticals.
2 other articles on this case.
View all »